Effects of glucocorticoid in patients with tuberculous pleurifis and its influnce on the expression of inflammatory cytokines IL-6 and IL-8

Decui Wang, Junling Wang, Junying Wang
{"title":"Effects of glucocorticoid in patients with tuberculous pleurifis and its influnce on the expression of inflammatory cytokines IL-6 and IL-8","authors":"Decui Wang, Junling Wang, Junying Wang","doi":"10.3760/CMA.J.ISSN.1673-8799.2016.02.008","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the effects of glucocortieoid in patients with tuberculous pleuritis and its impact on the level of inflammatory cytokines IL-6 and IL-8. \n \n \nMethods \nFrom January 2012 to June 2015,193 patients with tuberculous pleuritis were divided into research group and control group by random digits table methodin the TB Prevention Hospital of Binzhou City. The patients in two groups were all given anti-TB medication, and the research group was also given chest injection of dexamethasone treatment on the basis of anti-TB medication treatment. The clinical efficacy and IL-6 and IL-8 level change was observed. \n \n \nResults \n89 cases showed good effect, and 9 cases was invalid in research group and there were 74 and 21 cases in control group respectively, and there was significant difference between research group and control group (P 0.05). The levels of inflammatory cytokines IL-6 level after treatment of 3, 6 and 9 d in research group was lower than that in control group [(276.49±27.85) pg/ml vs (350.38±20.01) pg/ml,(195.32±14.35) pg/ml vs (312.51±14.82) pg/ml,(86.74±10.28) pg/ml vs (251.74±16.62) pg/ml, and there was significant difference(P<0.05).and IL-8 level[(576.51±19.79) pg/ml vs (850.64±27.70) pg/ml, (225.30±14.29) pg/ml vs (742.49±15.28) pg/ml, (127.68±11.23) pg/ml vs (443.47±12.63) pg/ml] \n \n \nConclusions \nIntrapleural injection of glucocorticoid in the treatment of tuberculous pleurisy, can make the drug directly acts on the chest, better realize the control of inflammatory cytokines, encourage pleural effusion absorption, improve the clinical symptoms early. It is worthy of clinical apphcation. \n \n \nKey words: \nGhcocorticoids; Tuberculous Pleurifis; Cell Inflammatory Cytokines","PeriodicalId":64135,"journal":{"name":"中国临床实用医学","volume":"74 1","pages":"27-30"},"PeriodicalIF":0.0000,"publicationDate":"2016-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床实用医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2016.02.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To investigate the effects of glucocortieoid in patients with tuberculous pleuritis and its impact on the level of inflammatory cytokines IL-6 and IL-8. Methods From January 2012 to June 2015,193 patients with tuberculous pleuritis were divided into research group and control group by random digits table methodin the TB Prevention Hospital of Binzhou City. The patients in two groups were all given anti-TB medication, and the research group was also given chest injection of dexamethasone treatment on the basis of anti-TB medication treatment. The clinical efficacy and IL-6 and IL-8 level change was observed. Results 89 cases showed good effect, and 9 cases was invalid in research group and there were 74 and 21 cases in control group respectively, and there was significant difference between research group and control group (P 0.05). The levels of inflammatory cytokines IL-6 level after treatment of 3, 6 and 9 d in research group was lower than that in control group [(276.49±27.85) pg/ml vs (350.38±20.01) pg/ml,(195.32±14.35) pg/ml vs (312.51±14.82) pg/ml,(86.74±10.28) pg/ml vs (251.74±16.62) pg/ml, and there was significant difference(P<0.05).and IL-8 level[(576.51±19.79) pg/ml vs (850.64±27.70) pg/ml, (225.30±14.29) pg/ml vs (742.49±15.28) pg/ml, (127.68±11.23) pg/ml vs (443.47±12.63) pg/ml] Conclusions Intrapleural injection of glucocorticoid in the treatment of tuberculous pleurisy, can make the drug directly acts on the chest, better realize the control of inflammatory cytokines, encourage pleural effusion absorption, improve the clinical symptoms early. It is worthy of clinical apphcation. Key words: Ghcocorticoids; Tuberculous Pleurifis; Cell Inflammatory Cytokines
糖皮质激素对结核性胸膜炎患者炎症因子IL-6、IL-8表达的影响
目的探讨糖皮质激素在结核性胸膜炎患者中的作用及其对炎症因子IL-6、IL-8水平的影响。方法选取2012年1月~ 2015年6月滨州市结核病预防医院结核性胸膜炎患者193例,采用随机数字表法分为研究组和对照组。两组患者均给予抗结核药物治疗,研究组在抗结核药物治疗的基础上给予胸部注射地塞米松治疗。观察两组临床疗效及IL-6、IL-8水平变化。结果研究组疗效良好89例,无效9例,对照组74例,无效21例,两组比较差异有统计学意义(P < 0.05)。研究组治疗3、6、9 d后炎症因子IL-6水平均低于对照组[(276.49±27.85)pg/ml vs(350.38±20.01)pg/ml,(195.32±14.35)pg/ml vs(312.51±14.82)pg/ml,(86.74±10.28)pg/ml vs(251.74±16.62)pg/ml,差异均有统计学意义(P<0.05)。和IL-8水平[(576.51±19.79)pg/ml vs(850.64±27.70)pg/ml,(225.30±14.29)pg/ml vs(742.49±15.28)pg/ml,(127.68±11.23)pg/ml vs(443.47±12.63)pg/ml]结论胸膜内注射糖皮质激素治疗结核性胸膜炎,可使药物直接作用于胸部,较好地实现对炎症因子的控制,促进胸腔积液的吸收,早期改善临床症状。具有临床应用价值。关键词:肾上腺皮质激素;结核性Pleurifis;细胞炎性细胞因子
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
6167
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信